共 95 条
- [1] Evaluating Systems Pharmacology Models Is Different From Evaluating Standard Pharmacokinetic Pharmacodynamic Models [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (02):
- [2] Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics [J]. PHYSIOLOGICAL REPORTS, 2018, 6 (05):
- [3] PHENYTOIN CUMULATION KINETICS [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) : 445 - 448
- [4] Efficient Generation and Selection of Virtual Populations in Quantitative Systems Pharmacology Models [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (03): : 140 - 146
- [6] [Anonymous], 2015, HDB UNCERTAINTY QUAN
- [7] [Anonymous], 2018, PHEN DIL HIGHL PRESC
- [8] [Anonymous], 2018, ASME V&V40-2018: Assessing credibility of Computational Modeling Through Verification and validation: Application to Medical Devices
- [9] Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (12): : 1479 - 1484